In 1996, Kari Stefansson has launched a new type of a biotechnology company and a brand new way to attack disease. Based in Iceland, his company, Decode Genetics plans to identify individual genetic markers, which lead to the company's most common diseases. To do this, he plans to create an unrivaled database of genetic and medical information, based on the unique Icelandic genealogical records and patient information from the database across the country, medical. But when a group of patients form a lawyer to oppose the plan, decode forced to change its strategy. "Hide
by Chris Bebenek, Debora L. Spar Source: Harvard Business School 19 pages. Publication Date: February 17, 2006. Prod. #: 706040-PDF-ENG
Related Case Solutions & Analyses:
Kingfisher Airlines: Managing Multiple Stakeholders
OpenIDEO
Fidelity Retires in Canada
Scenario-Based Strategy Maps
The Backyard Harvest: Outgrowing Hunger One Community at a Time
Amazon.com: The Brink of Bankruptcy, Spanish Version
Greenspan’s Conundrum
Management Caveats for Measuring and Assessing Public Responsibility Performance
The Hertz Corporation
Tesla Energy
